Interferon alfa-2a overdosage: Difference between revisions
Jump to navigation
Jump to search
(Created page with "__NOTOC__ {{Interferon alfa-2a}} {{CMG}} ==Overdosage== There are no reports of overdosage, but repeated large doses of interferon can be associated with profound lethargy, [...") |
|||
| Line 4: | Line 4: | ||
==Overdosage== | ==Overdosage== | ||
There | There is limited experience with overdosage. The maximum dose received by any patient was 7 times the intended dose of PEGASYS (180 mcg/day for 7 days). There were no serious reactions attributed to overdosages. Weekly doses of up to 630 mcg have been administered to patients with cancer. Dose-limiting toxicities were fatigue, elevated liver enzymes, neutropenia, and thrombocytopenia. There is no specific antidote for PEGASYS. Hemodialysis and peritoneal dialysis are not effective.<ref>{{Cite web | last = | first =|title = http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/103964s5204lbl.pdf| url =http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/103964s5204lbl.pdf | publisher = |date = | accessdate = }}</ref> | ||
==References== | ==References== | ||
Revision as of 01:12, 6 January 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overdosage
There is limited experience with overdosage. The maximum dose received by any patient was 7 times the intended dose of PEGASYS (180 mcg/day for 7 days). There were no serious reactions attributed to overdosages. Weekly doses of up to 630 mcg have been administered to patients with cancer. Dose-limiting toxicities were fatigue, elevated liver enzymes, neutropenia, and thrombocytopenia. There is no specific antidote for PEGASYS. Hemodialysis and peritoneal dialysis are not effective.[1]
References
- ↑ "http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/103964s5204lbl.pdf" (PDF). External link in
|title=(help)
Adapted from the FDA Package Insert.